Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.

Date publication

juillet 2020

Journal

Journal of neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis , Dr OMOROU Abdou Yacoubou

Tous les auteurs :
Kaminsky AL, Omorou AY, Soudant M, Pittion-Vouyovitch S, Michaud M, Anxionnat R, Guillemin F, Debouverie M, Mathey G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32617659

Résumé

Treatments may become redundant in older patients with multiple sclerosis (MS). Our aim was to explore whether stopping treatments might be possible in patients aged over 50 with disease inactivity.

Mots clés

Age, Disease inactivity, Disease-modifying treatments, Multiple sclerosis, Treatment discontinuation

Référence

J. Neurol.. 2020 Jul 2;: